Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.73 USD | +8.81% | -1.14% | +200.87% |
05-31 | Sector Update: Health Care Stocks Advance Friday Afternoon | MT |
05-31 | Ocugen Gets Recommendation For Dose Escalation in Eye Disease Trial; Shares Climb | MT |
Sales 2024 * | 671K 915K | Sales 2025 * | - | Capitalization | 445M 607M |
---|---|---|---|---|---|
Net income 2024 * | -59M -80.39M | Net income 2025 * | -81M -110M | EV / Sales 2024 * | 663 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-7.98
x | P/E ratio 2025 * |
-5.9
x | Employees | 65 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 98.37% |
Latest transcript on Ocugen, Inc.
1 day | +8.81% | ||
1 week | -1.14% | ||
1 month | +24.46% | ||
3 months | +80.21% | ||
6 months | +336.87% | ||
Current year | +200.87% |
Managers | Title | Age | Since |
---|---|---|---|
Shankar Musunuri
CEO | Chief Executive Officer | 60 | 12-12-31 |
Director of Finance/CFO | 42 | - | |
Jesse Simmers
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 76 | 22-03-16 | |
Director/Board Member | 74 | 20-04-04 | |
Ramesh Kumar
BRD | Director/Board Member | 68 | 19-09-26 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.01% | 2 M€ | -.--% |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 1.73 | +8.81% | 4,361,999 |
24-05-30 | 1.59 | -2.45% | 4,640,939 |
24-05-29 | 1.63 | -4.68% | 4,495,999 |
24-05-28 | 1.71 | -2.29% | 5,474,849 |
24-05-24 | 1.75 | -1.69% | 3,667,229 |
Delayed Quote Nasdaq, May 31, 2024 at 04:00 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+200.87% | 445M | |
+43.36% | 54.63B | |
-5.31% | 39.92B | |
+14.75% | 26.86B | |
-12.56% | 26.22B | |
-22.45% | 18.78B | |
+25.12% | 12.21B | |
+0.04% | 12.16B | |
+26.04% | 11.94B | |
-11.83% | 10.74B |
- Stock Market
- Equities
- OCGN Stock